We are live on
!
Find out more
O
OppenheimerFunds Portfolio holdings
AUM
$80.4B
1-Year Est. Return
15.1%
This Fund
S&P 500
This Quarter
Est. Return
+0.47%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
–
AUM
$80.2B
AUM Growth
-$2.64B
(-3.2%)
Cap. Flow
-$1.24B
Cap. Flow
% of AUM
-1.54%
Top 10 Holdings %
Top 10 Hldgs %
15.46%
Holding
1,891
New
54
Increased
680
Reduced
1,031
Closed
114
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$639M |
| 2 |
JPMorgan Chase
JPM
|
+$525M |
| 3 |
JD.com
JD
|
+$297M |
| 4 |
Itaú Unibanco
ITUB
|
+$222M |
| 5 |
ATVI
Activision Blizzard
ATVI
|
+$217M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$955M |
| 2 |
Citigroup
C
|
+$523M |
| 3 |
Nektar Therapeutics
NKTR
|
+$334M |
| 4 |
SLB Ltd
SLB
|
+$292M |
| 5 |
Alibaba
BABA
|
+$275M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.67% |
| 2 | Consumer Discretionary | 14.85% |
| 3 | Healthcare | 13.25% |
| 4 | Technology | 13.05% |
| 5 | Energy | 11.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HIMX
751
Himax Technologies
HIMX
$2.09B
| $5.73M | 0.01% |
930,056
+59,247
| +7% | +$498K |
|
752
Mercury Insurance
MCY
$6.07B
| $5.67M | 0.01% |
123,689
+16,012
| +15% | +$763K |
|
753
Tenet Healthcare
THC
$22.6B
| $5.58M | 0.01% |
230,153
-148,681
| -39% | -$2.96M |
|
754
Tower Semiconductor
TSEM
$22.9B
| $5.53M | 0.01% |
205,468
-51,086
| -20% | -$1.63M |
|
755
Pitney Bowes
PBI
$2.41B
| $5.47M | 0.01% |
502,415
-40,595
| -7% | -$503K |
|
|
ACH
756
Accendra Health
ACH
$249M
| $5.44M | 0.01% |
349,745
-504,685
| -59% | -$9M |
|
|
FTR
757
DELISTED
Frontier Communications Corp.
FTR
| $5.42M | 0.01% |
730,589
-27,010
| -4% | -$210K |
|
|
FRED
758
DELISTED
Fred's Inc
FRED
| $5.42M | 0.01% |
1,811,645
+99,333
| +6% | +$329K |
|
|
GSV
759
DELISTED
Gold Standard Ventures Corp.
GSV
| $5.4M | 0.01% |
3,310,312
| – | – |
|
760
Aecom
ACM
$9.57B
| $5.39M | 0.01% |
151,419
+10,813
| +8% | +$399K |
|
761
Jabil
JBL
$31.7B
| $5.34M | 0.01% |
185,773
-9,597
| -5% | -$261K |
|
762
Archer Daniels Midland
ADM
$40.1B
| $5.28M | 0.01% |
121,752
-109,328
| -47% | -$4.6M |
|
|
ARA
763
DELISTED
American Renal Associates Holdings, Inc
ARA
| $5.27M | 0.01% |
+279,578
| New | +$5.52M |
|
764
AngloGold Ashanti
AU
$39.9B
| $5.27M | 0.01% |
+555,000
| New | +$5.66M |
|
|
VRTV
765
DELISTED
VERITIV CORPORATION
VRTV
| $5.21M | 0.01% |
133,030
-57,820
| -30% | -$1.76M |
|
766
Sysco
SYY
$40.7B
| $5.18M | 0.01% |
86,453
-56,202
| -39% | -$3.4M |
|
767
Avnet
AVT
$7.07B
| $5.05M | 0.01% |
120,914
-10,855
| -8% | -$459K |
|
768
Ventas
VTR
$47.7B
| $5.01M | 0.01% |
101,096
-2,211,015
| -96% | -$116M |
|
769
TD Synnex
SNX
$19.8B
| $4.84M | 0.01% |
81,778
+10,678
| +15% | +$665K |
|
|
SPTN
770
DELISTED
SpartanNash
SPTN
| $4.73M | 0.01% |
275,024
+66,935
| +32% | +$1.44M |
|
|
DF
771
DELISTED
Dean Foods Company
DF
| $4.67M | 0.01% |
541,344
+343,508
| +174% | +$3.39M |
|
772
AstraZeneca
AZN
$267B
| $4.66M | 0.01% |
66,622
+15
| +0% | +$1.04K |
|
773
American Express
AXP
$227B
| $4.58M | 0.01% |
49,078
-1,954,938
| -98% | -$189M |
|
|
AXE
774
DELISTED
Anixter International Inc
AXE
| $4.58M | 0.01% |
60,409
-13,863
| -19% | -$1.08M |
|
775
HF Sinclair
DINO
$16.1B
| $4.5M | 0.01% |
92,166
+13,410
| +17% | +$638K |
|
Similar funds
TA
TCIM
HFS
SBAM
BB
SA
WF
BCPEM
OppenheimerFunds's Q1 2018 Portfolio in Review
As of Q1 2018, OppenheimerFunds held 1,891 positions worth $80.2B, down 3.2% from $82.8B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
OppenheimerFunds's Q1 2018 filing shows 54 new, 680 increased, 1,031 reduced and 114 closed positions. Its largest new stake was Avaya Holdings Corp. Common Stock: 5,049,928 shares worth $113M. The largest sale was Alphabet (Google) Class C, an estimated $955M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- OppenheimerFunds's largest Q1 2018 buy was Avaya Holdings Corp. Common Stock: 5,049,928 shares worth $113M.
- OppenheimerFunds added most to Alphabet (Google) Class A in Q1 2018, an estimated $639M increase.
- OppenheimerFunds's biggest Q1 2018 reduction was Alphabet (Google) Class C, cutting an estimated $955M.
- OppenheimerFunds fully exited Bioverativ Inc. Common Stock in Q1 2018, selling an estimated $77.3M.
- OppenheimerFunds's ten largest holdings make up 15% of its $80.2B portfolio in Q1 2018.
- OppenheimerFunds opened 54 new positions and closed 114 in Q1 2018.
- OppenheimerFunds's portfolio value fell 3.2% quarter-over-quarter to $80.2B.
Based on OppenheimerFunds's 13F filing for Q1 2018, filed 11 May 2018.